Combining immunotherapies effective against mouse model of cancer

Combining immunotherapies effective against mouse model of cancer Recent study results suggest that combining virotherapy and PD-1 blockades may be more effective than either approach alone Date: June 19, 2017 | Source: Nationwide Children's Hospital | See Original Here Summary: A recent study points to a new treatment strategy for rhabdomyosarcoma that takes advantage of…
Continue Reading »

At big cancer meeting, a big question: Is the U.S. ‘losing its edge’?

At big cancer meeting, a big question: Is the ‘losing its edge’? By LIZ SZABO — KAISER HEALTH NEWS | JUNE 2, 2017 | See Original Here Less and less of the research presented at a prominent cancer conference is supported by the National Institutes of Health, a development that some of the country’s top scientists…
Continue Reading »

Children who survive cancer face fewer serious long-term health issues – study

Children who survive cancer face fewer serious long-term health issues – study Report covering children diagnosed from 1970 to 1999 finds rate of severe long-term side effects dropped from to Jessica Glenza in Chicago, Illinois | The Guardian | Friday 2 June 2017  EDT | See Original Here The most dramatic drops in long-term health complications found…
Continue Reading »

TLC178 designated by US FDA as drug for rare paediatric disease in the treatment of Rhabdomyosarcoma

TLC178 designated by US FDA as drug for rare paediatric disease in the treatment of Rhabdomyosarcoma By Laxmi Iyer - April 26, 2017 | | See Original Here Taiwan Liposome Company, Ltd.,(TLC) (4152:TT) today announced that its oncology drug candidate TLC178 has been designated as a drug for a rare pediatric disease in the treatment of rhabdomyosarcoma…
Continue Reading »

Cancer Math and Rhabdomyosarcoma: Crowdfunding Request

Cancer Math and Rhabdomyosarcoma: Using engineering principles to develop personalized therapies for patients with rhabdomyosarcoma Last year Dr. Noah Berlow, a Postdoctoral Fellow at the Children's Cancer Therapy Development Institute (c-TDI) presented a webinar on the work he is doing in cancer math. With the reductions in federal research funding - and much greater cuts…
Continue Reading »

Childhood Cancer Survivors: Genetic Risk for Future Cancers?

Childhood Cancer Survivors: Genetic Risk for Future Cancers? Kate Johnson | April 05, 2017 | Medscape Medical News | See Original Here WASHINGTON – Almost 12% of childhood cancer survivors have genetic mutations that put them – or their children – at risk for future cancers, according to the first large-scale whole-genome sequencing study in this patient population. The…
Continue Reading »

New Blood Test May Pinpoint Cancer Tumors

New Blood Test May Pinpoint Cancer Tumors Written by Honor Whiteman | Healthline News |Published on March 6, 2017 | See Original Here Researchers say using DNA signatures may provide a diagnostic tool for cancer that isn't invasive.   New research shows promise for a blood test that not only identifies cancer but also pinpoints precisely where…
Continue Reading »

Instead of starving a cancer, researchers go after its defenses

Instead of starving a cancer, researchers go after its defenses Oxygen deprivation can propel tumor growth and spread BY LAURA BEIL | FEBRUARY 22, 2017 | ScienceNews | See Original Here | Magazine issue: Vol. 191 No. 4, March 4, 2017, p. 24 Oxygen Depreivation: Cancer cells (shown in blue) surround a blod vessel (red) in a mouse tumor. ells…
Continue Reading »

Immunotherapy: Could the Human Body Be Trained to Fight Cancer?

Immunotherapy: Could the Human Body Be Trained to Fight Cancer? Live Science - Health | By Balveen Kaurand  & Pravin Kaumaya, The Ohio State University | February 5, 2017 07:34am ET | See Original Here This article was originally published at The Conversation. The publication contributed the article to Live Science's Expert Voices: Op-Ed & Insights. The human immune…
Continue Reading »
Skip to toolbar